Medication Guide - 2/5/2021

Medication guides are FDA- approved documents that address issues that are specific to particular drugs, and can help patients avoid serious adverse events (side effects). This database does not include Medication Guides for FDA-approved allergenic or cellular/tissue products (see  FDA Online Label Repository  or DailyMed  for these Medication Guides).  More Drug Name Active Ingredient Form;Route Appl. No. Company Date Promacta Eltrombopag Olamine TABLET;ORAL 022291 NOVARTIS 02/03/2021 Promacta Kit Eltrombopag Olamine FOR SUSPENSION;ORAL 207027 NOVARTIS 02/03/2021 Orilissa Elagolix Sodium TABLET;ORAL 210450 ABBVIE INC 02/01/2021 Simponi Aria Golimumab INJECTABLE; INJECTION 125433 JANSSEN BIOTECH 02/01/2021 Gattex Kit Teduglutide Recombinant POWDER;SUBCUTANEOUS 203441 NPS PHARMS INC 01/29/2021 Nplate Romiplostim INJECTABLE; SUBCUTANEOUS 125268 AMGEN 01/29/2021 Plegridy Peginterferon Beta-1a INJECTABLE;INJECTION 125499 BIOGEN IDEC INC 01/29/2021 Manage Subscriptions  |  Unsubscribe All  |  Help This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA